1.80
                                            Inmune Bio Inc Aktie (INMB) Neueste Nachrichten
Short interest data insights for INmune Bio Inc.Trade Risk Assessment & Fast Gain Stock Tips - newser.com
Sentiment analysis tools applied to INmune Bio Inc.Weekly Trade Recap & Verified Swing Trading Watchlists - newser.com
Is INmune Bio Inc. stock overvalued by current metricsIPO Watch & Safe Capital Growth Trade Ideas - newser.com
Is INmune Bio Inc. a candidate for recovery playTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
Analyzing recovery setups for INmune Bio Inc. investorsPortfolio Gains Report & Verified Stock Trade Ideas - newser.com
Heatmap analysis for INmune Bio Inc. and competitorsMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com
Does INmune Bio Inc. stock trade at a discount to peersMarket Risk Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Statistical indicators supporting INmune Bio Inc.’s strengthEarnings Overview Report & Short-Term High Return Ideas - newser.com
What makes INmune Bio Inc. stock attractive to growth fundsQuarterly Profit Review & Stock Portfolio Risk Control - newser.com
Earnings visualization tools for INmune Bio Inc.Rate Cut & Safe Entry Point Identification - newser.com
Published on: 2025-11-02 21:20:18 - newser.com
Published on: 2025-11-02 20:37:16 - newser.com
Can volume confirm reversal in INmune Bio Inc.2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Inmune Bio Reports Q3 2025 Financial Results - MSN
How INmune Bio Inc. stock reacts to Fed rate cutsPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
INmune Bio, Inc. (NASDAQ:INMB) Q3 2025 Earnings Call Transcript - Insider Monkey
Will INmune Bio Inc. stock outperform tech sector in 2025Treasury Yields & Daily Chart Pattern Signal Reports - newser.com
Inmune Bio to Host Q3 Results Conference Call - MSN
What analysts say about INmune Bio Inc stockMarket Liquidity Analysis & High Return Trading Ideas - earlytimes.in
How INmune Bio Inc. stock benefits from global expansionJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com
Candlestick signals on INmune Bio Inc. stock todayWeekly Trading Summary & AI Optimized Trade Strategies - newser.com
Sector ETF performance correlation with INmune Bio Inc.July 2025 Trends & AI Driven Price Forecasts - newser.com
Earnings call transcript: INmune Bio beats Q3 2025 EPS forecast, stock dips - Investing.com Australia
Earnings call transcript: INmune Bio beats Q3 2025 EPS forecast, stock dips By Investing.com - Investing.com South Africa
Inmune Bio outlines 2026 regulatory milestones and cash runway through Q4 2026 - MSN
Is it time to cut losses on INmune Bio Inc.Weekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
Transcript : INmune Bio, Inc., Q3 2025 Earnings Call, Oct 30, 2025 - MarketScreener
INmune Bio Inc (INMB) Q3 2025 Earnings Call Highlights: Regulatory Progress and Financial ... - Yahoo Finance
INmune Bio Inc (INMB) Q3 2025 Earnings Call Highlights: Regulato - GuruFocus
INmune Bio Shrinks Losses While Analysts See Upside Ahead - Finimize
INMB Maintains Strong Cash Position with $27.7 Million on Hand - GuruFocus
INmune Bio Q3 net loss narrows to $6.5 mln, names new CEO - MarketScreener
[8-K] Inmune Bio, Inc. Reports Material Event | INMB SEC FilingForm 8-K - Stock Titan
INmune Bio Inc. (INMB) Q3 FY2025 earnings call transcript - Yahoo Finance
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update - The Manila Times
INmune Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
INMB posts Q3 loss and $16,514,000 impairment amid XPro setback - Stock Titan
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):